Amanta Healthcare Board to Consider Q2 and H1 Results on Nov 3, 2026
Amanta Healthcare Ltd 路 Intimation 路 03 Nov 2026, 5:30 am
Amanta Healthcare Board to Consider Q2 and H1 Results on Nov 3, 2026 Amanta Healthcare Limited announced that a meeting of its Board of Directors is scheduled for 3rd Nov'26 to consider and approve the unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the company stated that its trading window, which closed on 1st Oct'26 under SEBI insider trading regulations, will reopen on 6th Nov'26.
Original exchange filing (PDF)
More announcements from Amanta Healthcare Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vishal Ashokkumar Patel 路 18 Nov 2026
- submission of Disclosures under Regulation 7(2) of The SEBI (Prohibition of Insider Trading) Regulations, 2015 - off-market transfer of equity shares 路 18 Nov 2026
- Company Response On The Spurt In Volume Of Security Across Exchanges 路 14 Nov 2026
- The Exchange has sought clarification from Amanta Healthcare Ltd on November 13, 2026, with reference to Movement in Volume. <BR><BR>The reply is awaited. 路 13 Nov 2026
- Transcript of Post Results Conference call held on November 4, 2026 路 09 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jitendrakumar Jashbhai Patel 路 09 Nov 2026
- submission of Disclosure under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 (the "Insider Trading Regulations") 路 07 Nov 2026
- submission of Audio Recording of Post Results Conference Call held on November 4, 2026 路 04 Nov 2026
